Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib monotherapy in RA (DARWIN 2)
NCT01894516Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Oct 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 2 trial of filgotinib in rheumatoid arthritis (RA), sponsored by Galapagos NV. Started Oct 2013; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01894516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01894516.